|
June 9, 2008
|
|
IN
THIS ISSUE
WSU-DMC Battle
Goes To Lansing
Mich. Proton Beam Group Meets First Deadline
Bill Would Delay Reduction In Medicare
Physician Reimbursements
Kaiser Permanente, Microsoft Launch
EHR Pilot Program
Panel Discusses Expanding Coverage
Via 'Early Medicare' Program
AMA Applauds Genetic Anti-Discrimination
Law
WSU Docs In The News
CBO Looks At Tranparency As A Health
Cost Reducer
|
|
Click
Here To Contact Us
|
WSU-DMC
Battle Goes To Lansing
By
PAUL NATINSKY
With much passion and emotion but very little in terms of new developments,
the feud between the Wayne State University School of Medicine and
the Detroit Medical Center over residency programs and money went
statewide last week.
The
Senate Health Policy Committee, under the direction of
Chairman Dr. Tom George June 5 heard testimony from WCMSSM
President E. Chris Bush; Joe Schwarz, MD, a former congressman
and state legislator and current chair of a group formed
by the Detroit Regional Chamber to assess graduate medical
education in Southeast Michigan; DMC CEO Mike Duggan and
WSUSOM Executive Vice Dean Robert Frank, MD.
Dr.
Bush, who is also MSMS Board Secretary, emphasized the
importance of the WSU-DMC relationship in caring for the
indigent population in Detroit. He said medical students
have told him that they feel unsure about their future.
He added that, while 25 percent of WSU/DMC residents remain
in the Detroit area upon completion of their residencies, “medical
faculty at WSU could easily seek greener pastures elsewhere” but
maintain their commitment to the City of Detroit and its
patients.
He
said the real crisis is not for physicians, who will find
other opportunities, but for Detroit’s indigent.
Dr.
Schwarz’ remarks echoed those of LA Police brutality victim
Rodney King more than a decade ago: “Why can’t we all just
get along.”
“I
implore the leaders of both institutions to get down to
business and resolve this dispute,” said Dr. Schwarz. “It
is totally unacceptable that some days these institutions
are at each other’s throats, some days ignoring one another.
But they clearly aren’t playing in the same sandbox.”
Mike
Duggan outlined the history of the dispute with a parallel
analysis of his tenure at the DMC. He said that when he
first manned the helm at the medical center in 2004, it
was on the heels of a $50 million bailout from the State
of Michigan following $462 million in total losses from
1998-2003. He said he had 1,000 layoff notices on his desk
and recommendations to close Hutzel and Detroit Receiving
hospitals.
He
said he chose to execute none of this and, instead, to
run the place like a business. That included cutting overhead,
building patient volume by increasing emergency room visits,
adding accountability to the WSU-DMC contract and attracting
private doctors back to the DMC (as opposed to faculty
physicians. DMC is staffed by about 1,800 private doctors
and about 700 WSU faculty physicians).
Regarding
the WSU faculty group, Duggan focused his remarks on criticisms
of academic medicine, chiding the School of Medicine specifically
for postponing a patient’s appointment with a specialist
six weeks so that physician could pursue a research project
for the dean’s office and sending all of its physicians
in certain specialties to a conference at one time, leaving
coverage gaps, when the same conference occurred twice
each year.
He
hammered home that the sticking point for him in the WSU-DMC
relationship is accountability, or standards of performance,
in the contract with 700 faculty physicians that prevent
delays and gaps in coverage for patients.
Duggan
emphasized that 14 of 18 WSU/DMC groups remain in the joint
agreement and those groups have seen a net increase in
pay from $70.3 million in 2006 to $80.9 million in 2007.
“We’re
in the black and have hired 1,000 people since January,” he
said. “At the end of the day, we’re in the black for five
years and caring for (people) in the City of Detroit.
“We
can go back to the old way (when we gave the dean $80 million)
but we’ll be back to ask you (state government) for a bailout.”
Dr.
Frank looked back seven years when, he said, the School
of Medicine gave back $25 million in payments to keep the
DMC afloat and then watched as the medical center subsequently
and unilaterally defunded four residency programs, failed
to sign the term sheet (a sort of pre-contract) that resulted
from a mediator-brokered deal last fall and then last month
arbitrarily docked WSU faculty physicians $12 million claiming
that new Medicaid money from the state constituted a double
payment for services.
Dr.
Frank said DMC was fully aware of the additional state
money before signing the term sheet last fall. Further,
he said, even with the additional money, WSU faculty physicians
are providing services for about 57 cents on the dollar.
Dr.
Frank said that despite the difficulties created by the
WSU-DMC dispute, the faculty physicians continue to provide
the full range and volume of services they provided prior
to the $12 million cut.
“The
WSU/DMC powerhouse is in peril because the DMC can’t or
won’t honor the contract (term sheet),” said Dr. Frank.
In
response to an obvious but unasked question, Sen. Dr. George
said the committee took up this issue because “There are
$675 million a year in state funds spent between these
two institutions – it’s our job, that’s why this is on
the agenda.” He added that the constitutional requirement
for the legislature to provide for the health and welfare
of Michigan’s citizens paired with the fiduciary responsibility
resulting from the expenditure of state dollars makes this
dispute of great interest to the legislature.
Share
Your Thoughts on this Article
Back
to top
|
Mich.
Proton Beam Group Meets First Deadline
Six
Michigan health care systems have met a June 5 deadline
set by the state’s Certificate of Need commission, by submitting
a letter indicating that they have committed to a consortium
approach to bring proton beam therapy to the state.
The six are among the state’s largest health systems, and include
the state’s only two National Cancer Institute-designated comprehensive
cancer centers.
The letter to the CON commission, required to ensure the consortium
effort is moving forward, affirmed that these six health systems
have agreed to participate in the collaborative and contribute their
share of the start-up costs.
The consortium was formed to mitigate the costs of proton beam therapy – starting
with the $160 million needed to build a treatment center. At the
same time, a consortium will provide greater economic benefit to
Michigan than a single hospital provider, since it will spread an
economic benefit across a wide array of providers and communities.
In addition, a consortium ensures the state will have one proton
beam center operating at high efficiency, versus multiple centers
each operating at low volumes, risking financial and operational
viability. One high-efficiency center will also allow providers to
gain greater expertise at delivering this technology safely and effectively.
“Working together will ensure health care costs are carefully managed. The state
of Michigan and its citizens can’t afford to have individual institutions developing
their own proton beam programs. The collaborative will ensure appropriate utilization
and cost-management,” says Robert P. Kelch, MD, executive vice president for
medical affairs at the University of Michigan and chief executive officer of
the U-M Health System, which is part of the consortium.
Proton beam therapy is a type of radiation that is based on high-energy
particles called protons, whereas current radiation therapy uses
photons, or X-rays. Proton beam therapy appears to be most promising
for treating pediatric cancers and certain rare tumors in adults,
but more research is needed to fully understand the potential of
this treatment. The consortium approach will include a research component
to help define which patients will benefit from proton technology.
The consortium will next develop a business plan, which must be submitted
to the CON commission by Sept. 6.
The six health systems that have agreed to the collaborative to date
are:
• Barbara Ann Karmanos Cancer Center
• Genesys Hurley Cancer Institute
• Henry Ford Health System
• McLaren Health Care (the Great Lakes Cancer Institute-McLaren Campus)
• St. Joseph Mercy Hospital, Ann Arbor (Trinity Health)
• University of Michigan Health System
All high-volume hospital-based providers of radiation therapy services
in the state have been invited to join the consortium, and other
providers will be invited per state regulations. This will ensure
the greatest possible access to care for the most people in the state
who are in need of proton beam therapy.
The consortium approach is supported by a large number of providers,
purchasers and employers, as well as by the Economic Alliance of
Michigan, the Michigan Manufacturers Association and the Small Business
Association of Michigan.
For more information about Michigan’s proton beam consortium, visit
www.protontherapyformichigan
Share
Your Thoughts on this Article
Back
to top
|
Bill
Would Delay Reduction In Medicare Physician Reimbursements
Senate
Finance Committee Chair Max Baucus (D-Mont.)
on Friday introduced a bill (S
3101) that would delay for 18 months a 10.6
percent reduction in Medicare physician reimbursements
scheduled to take effect on July 1 and increase payments
by 1.1 percent, The
Hill reports.
The legislation, which includes a number of other provisions, would
cost about $20 billion. The bill includes provisions to promote electronic
prescribing and expand rural health care programs. In addition, the
legislation would require Medicare to promptly pay pharmacies for
medication dispensed to beneficiaries and impose new marketing restrictions
for Medicare Advantage plans (Young, The
Hill, 6/6). The bill would reduce the copayments that
beneficiaries pay for mental health services from 50 percent to 20
percent (AP/Albany
Times Union, 6/6).
According to The Hill,
although "Congress is under considerable pressure to prevent
this reduction and preserve beneficiaries' access to medical services," the
bill faces "several political and ideological barriers." For
example, the Bush administration has threatened to veto any legislation
that would reduce spending for MA (The
Hill, 6/6).
Share
Your Thoughts on this Article
Back
to top
|
Kaiser
Permanente, Microsoft Launch EHR Pilot Program
Officials
from Kaiser
Permanente and Microsoft on
Monday announced that the companies are developing a patient
information exchange pilot program, Reuters/Washington
Post reports (Kaufman, Reuters/Washington
Post, 6/9).
Under the program, patients who use Kaiser's personal electronic
health record system, My Health Manager, will be able to transfer
medical data -- including prescriptions, allergies, immunization
information and medical conditions -- from My Health Manager to Microsoft HealthVault accounts.
Users will be able to dictate what information is transferred and
will have access to their profile via the Internet (Lawton, Wall
Street Journal, 6/9). Initially, the program will only
be available to Kaiser's 156,000 employees (Reuters/Washington
Post, 6/9).
The pilot stage will last until November. If successful, the program
would then be offered to Kaiser's 8.7 million members in nine states
and Washington, D.C. (Lohr, New
York Times, 6/10). During the pilot stage, Kaiser
will be testing the program's security to ensure it meets safety
standards, according to Anna-Lisa Silvestre, Kaiser's vice president
of online services (Wall
Street Journal, 6/9).
Other electronic health information efforts are underway, including
a collaboration between Revolution
Health Group and Google,
which launched Google
Health in February (Reuters/Washington
Post, 6/9).
Silvestre said Kaiser also considered partnering with Google on its
project but chose Microsoft in part because of its privacy protection
and personal security technology. In addition, Microsoft and Kaiser
are using the same Web-based format, called a Continuity of Care
Document, while Google has focused its initial efforts on a Continuity
of Care Record Web format. Google and Microsoft each are committed
to supporting both formats, the Times reports.
Silvestre added, "Google will certainly be a player in this,
and we look forward to working with them. We're all for consumer
choice."
According to the New York Times,
analysts said the Kaiser program is significant because of the company's
size and "its reputation as an innovative user of information
technology." Silvestre said Kaiser's internal health record
system is doubling annually, adding that 2.25 million of its members
currently use it (New York Times, 6/9).
Share
Your Thoughts on this Article
Back
to top
|
Panel
Discusses Expanding Coverage Via 'Early Medicare' Program
At
a panel discussion on Friday, lawmakers and health experts
considered a Commonwealth
Fund proposal that
would provide health insurance to 44 million of the 48
million uninsured US residents, CQ
HealthBeat reports (Wyckoff, CQ
HealthBeat, 6/6).
Under the proposal, a government-operated connector authority would
offer lower-cost health plans, including a "Medicare Extra" plan
built on the existing Medicare system. All employers would be required
to provide coverage for workers or contribute up to 7 percent of
their payrolls into a fund to generate about $45 billion. Tax credits
would be used to ensure that premiums account for no more than 5
percent of income for lower-income families and 10 percent for higher-income
families. People who remained uninsured would automatically be enrolled
in a plan when their taxes are filed (Kaiser
Daily Health Policy Report, 5/13).
The plan also calls for the overhaul of health information technology,
evidence-based medicine, public health and the health payment system.
The Commonwealth Fund estimates that Medicare Extra premiums would
be 30 percent lower than employer-sponsored plan premiums. Proposal
co-author Cathy Schoen of the Commonwealth Fund on Friday said that
early coverage under Medicare is supported by 73 percent of older
US residents and 66 percent of US residents between ages 50-64 who
are currently covered by their employers.
Rep.
Tom Price (R-Ga.) questioned the idea of basing a health
insurance option on Medicare, saying, "It took us
40 years for us to get Medicare to see that it needed a
prescription drugs program." He added, "I think
we are brighter and better than the current system that
we have."
Cybele Bjorklund, Democratic staff director for the House
Ways and Means Committee, said that Medicare would be
a good model for expanding health insurance because it is efficient
and providers prefer it over private insurance (CQ
HealthBeat, 6/6).
A webcast of the panel discussion, sponsored by the Alliance
for Health Reform and the Commonwealth Fund,
is available online at kaisernetwork.org.
Share
Your Thoughts on this Article
Back
to top
|
AMA
Applauds Genetic Anti-Discrimination Law
President
Bush's signing of the Genetic Information Nondiscrimination
Act of 2007 into law last week-and Congress' approval of
the bill earlier this month-drew applause from the AMA,
which has long called for better patient privacy safeguards
as scientific advancements make it possible to individualize
health care for patients.
"Genetic testing holds great promise for improving public health, and patients
must be able to trust that their genetic information will be protected from inappropriate
and discriminatory uses," said AMA Trustee Edward L. Langston, MD. "This
new law will allow patients to take advantage of scientific advances in genetics,
such as screenings and therapies, without worrying that their personal health
information could be used against them by insurers or employers."
Share
Your Thoughts on this Article
Back
to top
|
WSU
Docs In The News
Zhe
Yang, PhD,
assistant professor of Biochemistry and Molecular Biology
with the Wayne State University School of Medicine, has
been awarded a four-year Scientist Development Grant
from the National American Heart Association to further
his research of an enzyme that could lead to new treatments
to combat heart arrhythmia and cardiac failure.
The
$308,000 award will fund research to develop a detailed
structural and functional understanding of SmyD1, a histone
methyltransferase specifically expressed in cardiac and
skeletal muscles. Histone modifications are now widely
recognized as a vital epigenetic mechanism that controls
diverse cellular processes, such as gene expression, chromatin
remodeling, DNA repairing and cell division. However, the
molecular details of the roles of histone modifications
in cardiovascular biology remain poorly understood.
His
own experience with epilepsy is leading Erik Brown to
a career in the field of neurology, with the possibility
of playing a role in international medicine.
The
first year MD/PhD student became interested in neurology
while in high school because of his own experiences with
epilepsy. “I decided that I definitely wanted to go to
medical school one day while working as an electrical engineering
co-op student with the biomedical company Cyberonics, makers
of the Vagus Nerve Stimulator,” he said.
Mr.
Brown, 26, is originally from Allen Park. Now living in
Dearborn, he completed his undergraduate studies at the
University of Michigan.
This
year, Mr. Brown captured first place in MD/PhD competition
and first place in the 2008 Medical Student Research Symposium
with research he conducted with Dr. Eishi Asano, MD, PhD,
assistant professor of pediatrics and neurology in the
Electrophysiology/Neurosurgery departments of Children's
Hospital of Michigan at Children's Hospital of Michigan.
A manuscript associated with the research, on which Mr.
Brown is first author, was accepted for publication by
the journal NeuroImage.
The
Medical Student Research Symposium competition requires
participants to orally present their research within 15
minutes to a diverse audience. The best presentations are
technical but understandable.
The
goal of the research, associated with the School of Medicine’s
Department of Anatomy and Cell Biology, was to determine
whether gamma-oscillations induced by auditory communication
localized language areas in pre-surgical evaluation of
children with focal epilepsy.
Zhiwei
Wang, PhD,
a postdoctoral fellow in the Department of Pathology,
received a $106,121 award from the US Department of Defense
for his research on the genes involved in the proliferation,
migration and invasion of prostate cancer cells.
Dr. Wang is investigating Jagged-1, a gene believed to be associated
with Hormone Refractory Prostate Cancer (HRPC) - a state the disease
sometimes reaches when hormone treatment is no longer affective -
and metastatic prostate cancer, the condition in which the disease
spreads from the prostate to other parts of the body.
Share
Your Thoughts on this Article
Back
to top
|
CBO
Looks At Transparency As A Health Cost Reducer
"Increasing
Transparency in the Pricing of Health Care Services
and Pharmaceuticals," Congressional
Budget Office: The CBO issue brief examines
whether increased transparency of specific health care
services and pharmaceuticals would help alleviate the
rapid growth in costs. According to the brief, several
factors among consumer and providers may limit the
effectiveness of transparency's ability to cut costs.
However, the brief notes that a greater awareness of
health care costs and who bears those costs might generate
increased demand for efficiency (CBO, "Increasing
Transparency in the Pricing of Health Care Services
and Pharmaceuticals," 6/5).
Share
Your Thoughts on this Article
Back
to top
|
|

This publication brought to you by Natinsky
Publishing Network.
Problems seeing this email? You may view it online at http://www.wcmssm.org
To subscribe or unsubscribe to this newsletter contact info@wcmssm.org
|
|
Wayne County Medical Society
of Southeast Michigan.
All Rights Reserved.
|